Auxilium Pharmaceuticals, Inc. (AUXL) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts AUXL Hot Sheet
Price: $36.47 --0%
Financial Fact:
Cost of goods sold: 25.71M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of goods sold: 25.71M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q1 EPS of ($0.04), $0.08 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $73.6 million versus the consensus estimate of $71.21 million.
For earnings history and earnings-related data on Auxilium Pharmaceuticals, Inc. (AUXL) click here.
For earnings history and earnings-related data on Auxilium Pharmaceuticals, Inc. (AUXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
